Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuanxin Technology is a China-based healthcare technology company that provides integrated services across the patient care journey, rather than a traditional drug-development biotech. Its business combines online and offline patient services, near-hospital and DTP pharmacy networks, internet hospital infrastructure, disease-management services, and healthcare payment and insurance solutions. The company operates major brands including Miaoshou Doctor, Yuanxin Pharmacy, Yuanxin Medical Technology, and Yuanxin Huibao, serving patients, physicians, hospitals, pharmaceutical companies, and insurers. Yuanxin appears to be focused on commercialization and service delivery at scale in China, with hundreds of hospital partnerships and a large pharmacy footprint. It is best characterized as a commercial digital-health and healthcare services platform rather than a therapeutics pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuanxin Technology.